June 2025
1. HAZENBROEK M, Pengel LHM, Sassen SDT, Massey EK, et al
   Removing the physician from the equation: Patient-controlled, home-based therapeutic drug self-monitoring of tacrolimus.
   Br J Clin Pharmacol. 2025;91:1560-1568.
   

   >> Share

   
   November 2024
2. LEINO AD, Takyi-Williams J, Park JM, Norman SP, et al
   Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression.
   Br J Clin Pharmacol. 2024;90:2897-2909.
   

   >> Share

   
   
3. SAQR A, Al-Kofahi M, Mohamed M, Dorr C, et al
   Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.
   Br J Clin Pharmacol. 2024;90:2837-2848.
   

   >> Share

   
   October 2024
4. AGERGAARD K, Thiesson HC, Carstens J, Staatz CE, et al
   Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients.
   Br J Clin Pharmacol. 2024 Oct 10. doi: 10.1111/bcp.16277.
   

   >> Share

   
   June 2024
5. VAN GELDER T, Gelinck A, Meziyerh S, de Vries APJ, et al
   Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve-based monitoring?
   Br J Clin Pharmacol. 2024 Jun 6. doi: 10.1111/bcp.16098.
   

   >> Share

   
   February 2024
6. KHAMLEK K, Komenkul V, Sriboonruang T, Wattanavijitkul T, et al
   Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.
   Br J Clin Pharmacol. 2024;90:406-426.
   

   >> Share

   
   December 2023
7. PASCHIER A, Destere A, Monchaud C, Labriffe M, et al
   Tacrolimus population pharmacokinetics in adult heart transplant patients.
   Br J Clin Pharmacol. 2023;89:3584-3595.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share